The uptake of adolescent vaccinations through the School Immunisation Program in specialist schools in Victoria, Australia
- PMID: 30522907
- DOI: 10.1016/j.vaccine.2018.11.034
The uptake of adolescent vaccinations through the School Immunisation Program in specialist schools in Victoria, Australia
Abstract
Background: As part of the National Immunisation Program (NIP) students in Australia receive adolescent immunisations through the School Immunisation Program at 12 to 13 years. For children with disabilities attending specialist schools, no vaccine uptake data is collected at this time point. We aimed to determine uptake of diphtheria-tetanus-pertussis (dTpa) and Human Papillomavirus (HPV) immunisations amongst young people with disabilities in specialist schools in Victoria.
Methods: A prospective cohort study was conducted in Victoria, Australia. Data was collected on immunisation days in the 2017 school year from specialist schools in Victoria. The school immunisation coordinator entered data online for eligible students for receipt of dTpa and HPV on each school immunisation day. Demographic data, motor and intellectual function of students and reasons for non-receipt of dTpa and HPV vaccine were recorded. Data were analysed using descriptive statistics.
Results: Of 73 eligible specialist schools in Victoria, 28 (38%) participated. dTpa was received by 63% (237/374) of participating students and HPV dose 1 (HPV1) was received by 66% (76/114) females and 67% (174/260) male students respectively. Three doses of HPV were received by only 41% (100/241) of students. The main reasons for missed immunisation were absence from school, lack of consent and inability to immunise due to the student's behaviour and/or anxiety.
Conclusion: This is the first study in Australia to report that uptake of adolescent immunisations in specialist schools for young people with a disability is significantly lower than in mainstream settings. Comparative data during the same time period for students in mainstream schools demonstrated higher uptake, at 89% for dTpa and 75% for three doses of HPV. These data highlight the inequity of receipt of school-based immunisations for this group of adolescents, the barriers to which could be more thoroughly explored through qualitative inquiry from a socio-ecological perspective.
Keywords: Adolescent immunisation; Disability; Immunisation uptake.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Stakeholder perspectives of immunisation delivery for adolescents with disability in specialist schools in Victoria, Australia: 'we need a vaccination pathway'.BMC Public Health. 2024 Jul 23;24(1):1973. doi: 10.1186/s12889-024-19322-y. BMC Public Health. 2024. PMID: 39044189 Free PMC article.
-
Potential process improvements to increase coverage of human papillomavirus vaccine in schools - A focus on schools with low vaccine uptake.Vaccine. 2020 Mar 23;38(14):2971-2977. doi: 10.1016/j.vaccine.2020.02.047. Epub 2020 Feb 27. Vaccine. 2020. PMID: 32115296
-
Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada.Vaccine. 2015 Apr 8;33(15):1786-90. doi: 10.1016/j.vaccine.2015.02.047. Epub 2015 Feb 27. Vaccine. 2015. PMID: 25731789
-
Adolescent and young adult HPV vaccination in Australia: achievements and challenges.Prev Med. 2011 Oct;53 Suppl 1:S29-35. doi: 10.1016/j.ypmed.2011.08.015. Prev Med. 2011. PMID: 21962468 Review.
-
Improved population coverage of the human papillomavirus vaccine after implementation of a school-based vaccination programme: the Singapore experience.Singapore Med J. 2023 May;64(5):294-301. doi: 10.11622/smedj.2022053. Singapore Med J. 2023. PMID: 35546141 Free PMC article. Review.
Cited by
-
Measuring school level attributable risk to support school-based HPV vaccination programs.BMC Public Health. 2022 Apr 25;22(1):822. doi: 10.1186/s12889-022-13088-x. BMC Public Health. 2022. PMID: 35468743 Free PMC article.
-
Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in the Valencian Community-Spain (2008-2018).Vaccines (Basel). 2020 Mar 2;8(1):117. doi: 10.3390/vaccines8010117. Vaccines (Basel). 2020. PMID: 32131535 Free PMC article.
-
Immunization Coverage, Equity, and Access for Children with Disabilities: A Scoping Review of Challenges, Strategies, and Lessons Learned to Reduce the Number of Zero-Dose Children.Vaccines (Basel). 2025 Mar 31;13(4):377. doi: 10.3390/vaccines13040377. Vaccines (Basel). 2025. PMID: 40333239 Free PMC article. Review.
-
Use of Apps to Promote Childhood Vaccination: Systematic Review.JMIR Mhealth Uhealth. 2020 May 18;8(5):e17371. doi: 10.2196/17371. JMIR Mhealth Uhealth. 2020. PMID: 32421684 Free PMC article.
-
Uptake of HPV Vaccine among young adults with disabilities, 2011 to 2018.Disabil Health J. 2022 Oct;15(4):101341. doi: 10.1016/j.dhjo.2022.101341. Epub 2022 May 13. Disabil Health J. 2022. PMID: 35659860 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials